Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 20, 2022

SELL
$278.73 - $327.27 $374,334 - $439,523
-1,343 Closed
0 $0
Q3 2021

Nov 12, 2021

SELL
$221.6 - $272.71 $50,968 - $62,723
-230 Reduced 14.62%
1,343 $310,000
Q2 2021

Aug 16, 2021

BUY
$180.55 - $233.54 $284,005 - $367,358
1,573 New
1,573 $361,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Hall Private Wealth Advisors Portfolio

Follow Hall Private Wealth Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hall Private Wealth Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Hall Private Wealth Advisors with notifications on news.